The involvement of distraction in memory deficits induced by NMDAR antagonism: Relevance to cognitive deficits in schizophrenia

被引:9
作者
Grayson, Ben [1 ]
Adamson, Lisa [1 ]
Harte, Michael [1 ]
Leger, Marianne [1 ]
Marsh, Samuel [1 ]
Piercy, Chloe [1 ]
Neill, Joanna C. [1 ]
机构
[1] Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England
关键词
Phencyclidine; Object recognition memory; Schizophrenia; Cognition; Rat; Animal models; ANTERIOR CINGULATE CORTEX; OBJECT RECOGNITION; WORKING-MEMORY; LESIONS; MODEL; TASK;
D O I
10.1016/j.bbr.2014.03.011
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Recognition memory, impaired in neuropsychiatric conditions and currently untreated, may be assessed by the novel object recognition (NOR) task with robust impairments induced by sub-chronic treatment with the N-methyl-o-aspartate receptor antagonist phencyclidine (PCP). The aim of the present study was to investigate how sub-chronic PCP produces its effects in this task. Forty adult female rats received vehicle or PCP (2 mg/kg i.p. twice daily for 7 days followed by 7 days washout). Rats completed a 3-min acquisition trial followed by differential inter-trial-interval (M) conditions (1 min in the home cage, 10 s in the home cage, 1 min in the NOR test box in the presence of an unfamiliar object or 1 min in the NOR test box completely undisturbed) followed by a 3-min retention trial. Control rats spent significantly more time exploring the novel compared with the familiar object in retention. This effect was abolished in the sub-chronic PCP treated animals following all ITI conditions except in rats left completely undisturbed in the NOR test box for a 1 min ITI. The combined influence of sub-chronic PCP treatment and the effect of distraction provides further support for the validity of the NOR test in mimicking cognitive deficits of relevance to schizophrenia. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 192
页数:5
相关论文
共 50 条
  • [1] Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model
    Mitsadali, Idil
    Grayson, Ben
    Idris, Nagi F.
    Watson, Linzi
    Burgess, Matthew
    Neill, Joanna
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (07) : 695 - 708
  • [2] Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
    Vigano, Daniela
    Guidali, Cinzia
    Petrosino, Stefania
    Realini, Natalia
    Rubino, Tiziana
    Di Marzo, Vincenzo
    Parolaro, Daniela
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2009, 12 (05) : 599 - 614
  • [3] Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia
    Damgaard, Trine
    Plath, Niels
    Neill, Jo C.
    Hansen, Suzanne L.
    PSYCHOPHARMACOLOGY, 2011, 214 (02) : 403 - 413
  • [4] Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats
    Amitai, Nurith
    Markou, Athina
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) : 67 - 80
  • [5] Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
    Lesh, Tyler A.
    Niendam, Tara A.
    Minzenberg, Michael J.
    Carter, Cameron S.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (01) : 316 - 338
  • [6] Cognitive Deficits in Schizophrenia
    Kayman, Deborah J.
    Goldstein, Marjorie F.
    CURRENT GERIATRICS REPORTS, 2012, 1 (01): : 45 - 52
  • [7] Cognitive Deficits in Schizophrenia
    Deborah J. Kayman
    Marjorie F. Goldstein
    Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1 (1): : 45 - 52
  • [8] The effects of donepezil on phencyclidine-induced cognitive deficits in a mouse model of schizophrenia
    Li, Yi-Xuan
    Ye, Zi-He
    Chen, Tong
    Jia, Xiao-Feng
    He, Ling
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2018, 175 : 69 - 76
  • [9] Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia
    Trine Damgaard
    Niels Plath
    Jo C. Neill
    Suzanne L. Hansen
    Psychopharmacology, 2011, 214 : 403 - 413
  • [10] Cognitive deficits as treatment targets in schizophrenia
    Gold, JM
    SCHIZOPHRENIA RESEARCH, 2004, 72 (01) : 21 - 28